Lung bacteria morph into lethal form
Cystic-fibrosis lungs could be cleared by flicking a bacterial switch.
US researchers have identified how bacteria lining the lungs of cystic-fibrosis patients switch into a deadly modesup>1. Altering this switch could lead to more effective therapies for potentially lethal infections.
Tough layers of bacteria called biofilms build up in the lungs of patients suffering from cystic fibrosis, often resulting in their death. Biofilms are hard to shift with antibiotics – but how they acquire this drug resistance has previously been unclear.
The normally innocuous bacteria undergo a phase-shift that switches on both antibiotic resistance and an enhanced ability to form biofilms, Eliana Drenkard and Frederick Ausubel of Harvard Medical School in Boston have found.
The pair also identified a protein that triggers the switch – and could make a potential drug target. A molecule that shunts the bacteria back into an antibiotic-susceptible state could be co-administered with conventional treatments to make the latter more effective. „If we could trick the bacteria into the antibiotic-susceptible phase, then antibiotics would be much better at destroying them,“ says Ausubel.
„It is very exciting work,“ says George OToole, who studies biofilms at Dartmouth Medical School in Hanover, New Hampshire. There may be additional ways to target the resistant cells and prevent biofilms building up in the body or elsewhere; identifying these, he says, is the challenge that lies ahead.
Tough individuals
It had been thought that biofilms themselves are inherently resistant to antibiotics because of their thick outer coating. But Drenkard and Ausubels work suggests that Pseudomonas aeruginosa first switch to a drug-resistant form and that this helps them to form super-resistant layers. „It suggests that high antibiotic resistance is linked to the functions required to actually make the biofilm,“ says OToole.
Drenkard and Ausubel found that natural variations among bacteria enable some of them to survive in the presence of antibiotics, when a bunch of them are grown in a dish. When grown without antibiotics, however, the bugs revert to their original non-resistant, non-biofilm-forming state.
The same variants exist in the lungs of cystic-fibrosis patients being treated with antibiotics, they found. An environmental cue, such as the altered salt concentrations found in the lungs of patients, may trigger the phase-shift, Ausubel suggests.
He believes that a small population of bacteria in patients lungs pre-exist in the resistant form. When the patients are treated with antibiotics, only these bugs survive and so establish a chronic infection.
In the wild, however, phase-shifting is an essentially random switching mechanism. Bacteria use it to express characteristics that help them to survive in a particular environment; salmonella and cholera bacteria also undergo phase-shifts.
References
- Drenkard, E. & Ausubel, F. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature, 416, 740 – 743, (2002).
Media Contact
Alle Nachrichten aus der Kategorie: Medizin Gesundheit
Dieser Fachbereich fasst die Vielzahl der medizinischen Fachrichtungen aus dem Bereich der Humanmedizin zusammen.
Unter anderem finden Sie hier Berichte aus den Teilbereichen: Anästhesiologie, Anatomie, Chirurgie, Humangenetik, Hygiene und Umweltmedizin, Innere Medizin, Neurologie, Pharmakologie, Physiologie, Urologie oder Zahnmedizin.
Neueste Beiträge
Nanofasern befreien Wasser von gefährlichen Farbstoffen
Farbstoffe, wie sie zum Beispiel in der Textilindustrie verwendet werden, sind ein großes Umweltproblem. An der TU Wien entwickelte man nun effiziente Filter dafür – mit Hilfe von Zellulose-Abfällen. Abfall…
Entscheidender Durchbruch für die Batterieproduktion
Energie speichern und nutzen mit innovativen Schwefelkathoden. HU-Forschungsteam entwickelt Grundlagen für nachhaltige Batterietechnologie. Elektromobilität und portable elektronische Geräte wie Laptop und Handy sind ohne die Verwendung von Lithium-Ionen-Batterien undenkbar. Das…
Wenn Immunzellen den Körper bewegungsunfähig machen
Weltweit erste Therapie der systemischen Sklerose mit einer onkologischen Immuntherapie am LMU Klinikum München. Es ist ein durchaus spektakulärer Fall: Nach einem mehrwöchigen Behandlungszyklus mit einem immuntherapeutischen Krebsmedikament hat ein…